Back to top

Genmab reports Q2 net sales of Darzalex $4.207B

Genmab (GMAB) announced that worldwide net trade sales of DARZALEX, or daratumumab, including sales of the subcutaneous, or SC, product, daratumuma...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Genmab A/S Sponsored ADR (GMAB)

Johnson & Johnson (JNJ)